Combining Novel Agents for CLL

Jennifer Brown, MD, PhD

Video Categories: CLL

Dr. Jennifer R. Brown talks about combining novel agents for treating CLL as the next step to achieve longer remissions for patients. Until now, novel agents have only been used individually or in combination with antibodies. New studies are being designed to measure the efficacy of combining novel agents with each other for improved outcomes.

Related Videos

September 7, 2018

The Future of Genomics and Targeted Therapies

Dr Andrey Antov muses on the evolution of genomics and how it could potentially impact targeted therapies and cancer care.

September 2, 2015

Challenges with Oral Oncolytics

Dixie-Lee Esseltine, MD and George Mulligan, PhD address the challenges that they foresee for patients as more oral oncolytics are developed.